Atlas FDA

PARVOVIRUS B19 IGG ENZYME IMMUNOASSAY

FDA premarket approval P970054/S005 · decided 2007-10-10

Approval details

PMA number
P970054
Supplement
S005
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
PARVOVIRUS B19 IGG ENZYME IMMUNOASSAY
Generic name
ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG
Applicant
Diasorin
Date received
2007-06-04
Decision date
2007-10-10
Days to decision
128 days
Decision code
APPR
Product code
MYL
Advisory committee
Microbiology
Expedited review
No
Location
Stillwater, MN
Statement
APPROVAL FOR THE REDUCTION IN PLATE WASH VOLUME.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
LIAISON ALDOSTERONE, LIAISON ALDOSTERONE CONTROL SET, LIAISON ALDOSTERONE CALIBRATION VERIFIERS (K130321)Diasorin2013-04-09